FDA approves AstraZeneca, Nektar constipation drug
September 16, 2014 at 10:27 AM EDT
Sept 16 (Reuters) - The U.S. Food and Drug Administration approved an oral therapy to treat opioid-induced constipation developed by Nektar Therapeutics and AstraZeneca Plc .
